Medical Writing

Clinical reporting expertise

Convert the complexity of your clinical trial information into clear, understandable documentation. Our medical writing services provide full support for Phase I–IV clinical trials and medical device study documentation.

In-depth industry expertise


Our global team of medical writers produces technical and scientific documentation for a wide range of studies for both the EMA and FDA. Our writers have experience in over 40 therapeutic areas and hundreds of indications, and are native or fluent English speakers, with additional bilingual writing capabilities.

Comprehensive support for all your documents:

  • Protocols
  • EMA and FDA Briefing Packages
  • Investigator Brochures
  • Clinical Study Reports (CSR)
  • Marketing Documentation
  • Posters and/or Abstracts
  • Customized reports based on client requests
  • Development of scientific publications

Why choose Alira Health?

Together, the CROS NT and Alira Health biometrics team has provided expert statistical guidance for over 500 projects. As our partner, you’ll benefit from:

  • In-depth expertise across the complete clinical trial process
  • Flexible, tailored service delivered by global multidisciplinary teams
  • Efficient, safe, and successful study leadership
  • Exceptional customer service and site relations
  • Frequent, transparent, and professional communication
  • Comprehensive statistical guidance for regulatory communication and submission, study-based data management, biostatistics, and statistical programming

Related News

Events February 2, 2023
ACDM 2023
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
Clinical Data Science
Blog December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Blog December 14, 2022
How to Optimize Clinical Research with Patient Advisory Boards
Patient engagement is increasingly essential to all stages of product development—particularly clinical research.
Clinical Patient Advocacy Patient Centric
Events November 30, 2022
Innovations in Wound Healing
We are excited to attend and sponsor a poster presentation at the Innovations in Wound Healing event this year. This unique meeting is led by a group of experienced educators, scientists(...)
Clinical Patient Centric Wound Healing
Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Blog September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Blog September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.